111 Inc. (YI)
YI trades on Nasdaq in Consumer Staples, Retail-Drug Stores and Proprietary Stores. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1738906/000110465926052002/0001104659-26-052002-index.htm. Net income: SEC 20-F (us-gaap:ProfitLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | YI on Nasdaq |
| Sector | Consumer Staples |
| Industry | Retail-Drug Stores and Proprietary Stores |
| Country | China |
| IPO year | 2018 |
| SEC CIK | 0001738906 |
| SEC industry code | Retail-Drug Stores and Proprietary Stores |
| Incorporated in | Cayman Islands |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.8B |
| Net income | -$3.2M |
| Operating income | -$340K |
| Net margin | -0.2% |
| Operating margin | -0.0% |
| Revenue growth | -9.0% |
| Cash | $73.1M |
| Total assets | $314.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.0× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These conditions, along with other matters as set forth in Note 2, raises substantial doubt about the Company's ability to continue as a going concern." | 20-F 2026-04-30 |
| Cash and burn | $73.1M cash; operating cash flow $4.3M a quarter. | Report 2025-12-31 |
| Shares outstanding | 8,785,115 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Grant Thornton Zhitong Certified Public Accountants LLP, Shanghai, China | PCAOB Form AP 2026-05-13 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $93K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $1.8B | -$3.2M | $17.0M | $73.1M | $26.8M | $1.8B | 20-F 2026-04-30 |
| FY 2024 2024-12-31 | $2.0B | -$2.8M | $36.0M | $63.3M | $22.1M | $2.0B | 20-F/A 2025-08-29 |
| FY 2023 2023-12-31 | $2.1B | -$49.8M | -$63.0M | $85.0M | $47.6M | $2.1B | 20-F 2024-05-14 |
| FY 2022 2022-12-31 | $2.0B | -$54.5M | -$3.4M | $97.7M | $26.0M | $2.0B | 20-F 2023-04-28 |
| FY 2021 2021-12-31 | $1.9B | -$97.5M | -$108.1M | $103.8M | $40.7M | $1.9B | 20-F 2022-04-29 |
| FY 2020 2020-12-31 | $1.3B | -$71.6M | -$17.9M | $182.3M | $35.1M | $1.3B | 20-F 2021-04-30 |
| FY 2019 2019-12-31 | $567.7M | -$72.1M | -$73.6M | $83.5M | $13.7M | $567.7M | 20-F 2020-04-16 |
| FY 2018 2018-12-31 | $259.8M | -$55.6M | -$49.9M | $124.2M | No debt tags | $259.8M | 20-F 2019-04-10 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2018-09-13 |
| Latest annual report | 20-F | 2026-04-30 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-26 |
Source: SEC EDGAR submissions feed, 133 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -2.1% |
| 1 month | -8.4% |
| 3 months | -25.3% |
| Year to date | +10.9% |
| 1 year | -29.9% |
| From 52-week high | -66.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Retail-Drug Stores and Proprietary Stores
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PETS | PetMed Express Inc. | $0.8977 | -4.52% | $20.0M |
| RDGT | Ridgetech Inc. | $1.01 | -4.72% | $3.7M |
| GRDN | Guardian Pharmacy Services Inc. | $49.43 | -0.18% | $3.1B |
| CVS | CVS Health Corporation | $88.59 | -0.85% | $113.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier